COCH - Press Releases Detail
Summary
Billionaire Entrepreneur Glen Taylor Commits to a 5-Year Facility to Support Companys upcoming FDA Clinical Trial for the Acclaim\xae Fully Implanted Cochlear ImplantWHITE BEAR LAKE, Minnesota, March 04, 2024 (GLOBE NEWSWIRE) -- Envoy Medical\xae, Inc. (Envoy Medical) (NASDAQ: COCH), a revolutionary hearing health company focused on fully implanted hearing systems, today announced the closing of up to a $10 million, five-year lending facility provided by existing investor and billionaire entrepreneur Glen Taylor. Our revolutionary design leveraging the natural ear to pick up sound rather than a microphone is an opportunity to dramatically change the landscape for hearing health, using new, fully implantable technologies. Should the bill become law, it would provide greater patient access to important technologies and encourage more innovation and competition within the category. It is not currently covered by Medicare or Medicaid, and is not widely covered by private insurers.To learn more about the Esteem implant, visit https://www.envoymedical.com/middle-ear-implants.Additional Information and Where to Find ItCopies of the documents filed by Envoy Medical with the SEC may be obtained free of charge at the SECs website at .This press release includes forward-looking statements within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this press release reflect Envoy Medicals current views about future events and are subject to numerous known and unknown risks, uncertainties, assumptions and changes in circumstances that may cause its actual results to differ significantly from those expressed in any forward-looking statement.